[Gonadotropin and steroid hormone excretion during treatment with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D000728:Androgens / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D004967:Estrogens / Q000652:urine*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D007986:Luteinizing Hormone / Q000652:urine; D008297:Male; D008875:Middle Aged
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D045930:Anabolic Agents; D000728:Androgens; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Die Gonadotropin- und Steroidhormon-Ausscheidung während der Behandlung mit 1-alpha-Methyl-5-alpha-androstan-17-beta-ol-3-on (Mesterolon)